![]()
Written by Elena Schellpfeffer, 2026 PROMISE Scholar
What is your background in education that led you to where you are now?
I grew up in Chile, and when I was in high school, I started to like biology and chemistry, so I decided to major in biochemistry in undergrad. I also had the idea of doing medicine but decided not to do that in the end. In college I realized that, at least in my country, there’s not many options for work apart from academia. I have always been academically inclined, and I like studying things and science in general. I wouldn’t have liked to have a career that has a more mundane purpose.
What does your lab study?
There is a system within the cells that gets rid of proteins that need to be gone. Proteins in the cell do all the work, but they need to be turned over. They are made and removed all the time, and one of the systems that does that is the ubiquitin system. It marks the protein for degradation and removes it. However, the problem is that many diseases are associated with the function of that system. If the system is not working well, then there is an accumulation of proteins that should not be there or are not required at certain moments. It can affect different organs in different ways. There are about 1000 proteins that are involved in regulating the system, because the cells need to choose what specific protein is getting removed. Otherwise, if it wasn’t so specific, all the proteins would be removed at the same time. It’s very specific and depends on what cell type it is. It’s completely different in a neuron than in a T-cell. So, we focus on diseases that are developmental and genetic, meaning that people are born with them. Also, we mostly study intellectual disabilities, and that’s because they have a mutation in one of the genes of the system. We know that the genes have mutations on them, but we have no idea what the protein does. We are interested in understanding the fundamental functions of the protein, and seeing what goes wrong when they are mutated. For that we use biochemical techniques and the cell culture of stem cells. We aim to model development in a dish with the stem cells.
What do you like to do outside of the lab?
I like to see my friends and play soccer. Just a few hobbies, like playing video games and listening to music as well.
Besides what you study, are there any fields that interest you?
In general, I like developmental biology, which is when people use model organisms to study development in a whole organism. What I do with stem cells is very far removed from that. Developmental biology is cool. You can see what’s going on with the different genes using frogs, flies, worms, etc. All of them are very interesting. However, I have the advantage of working with human cells, but they lack the complexity of a whole organism.
What is a new development in your field that interests you?
There is currently a new hot topic in my field. So, sometimes the system [ubiquitin] fails, and it can lead to developmental genetic disorders, but also to neurodegenerative diseases in general, with the most famous ones being when there is protein accumulation which happens in Alzheimer’s, Parkinson’s, and ALS. They happen because of a failure to degrade proteins, so they get accumulated in the brain or other places, and the cells simply die because it is toxic. Understanding how this system works can help for those diseases, because if a protein gets accumulated in the wrong place, we want to get rid of it with drugs, so treat it. Currently there is a technology that has been developed in the field where they mimic or try to force a protein to get close to an enzyme that degrades that protein. So, we add that drug and it will connect to that protein and send it to degradation, which is called PROTAC. Recently, there has been the first FDA approved prototype that will induce the degradation of a protein and remove it artificially. If an enzyme is not working, then we can force the protein to go to another enzyme to then degrade the protein. This is a promising new field that could help diseases with issues with protein degradation.
Education Pathway:
Undergraduate Degree: Pontificia Universidad Catolica de Chile
Doctoral Program (Ph.D.): Pontificia Universidad Catolica de Chile – Cell & Molecular Biology
Post-doctoral Research: University of Dundee, Scotland – Greg Findlay’s Lab